- Compounded topical finasteride products lack FDA approval.
- Adverse effects include sexual dysfunction and mood disturbances.
- Risks persist even after discontinuation.
- Potential risks should be discussed with patients.
- Healthcare professionals should report adverse events to the FDA MedWatch program.
Source: FDA
